A study, published in JAMA, examined how providing physicians with lists of nonadherent patients impacted fecal immunochemical test and colorectal cancer screening participation.
Cedric Rat, MD, of Nantes, France-based Faculty of Medicine, and colleagues conducted a three-group, cluster-randomized study of 801 practices which treated patients between 50 and 74 years old that were not current with their CRC screening.
Researchers assigned physicians to one of three groups:
- Providers receiving a list of patients who had not undergone CRC screening: 496
- Providers receiving a letter describing region-specific adherence rates: 495
- Providers conducting usual care: 455
Researchers measured CRC screening participation rates among the three groups.
Here's what you should know:
1. Of 1,482 physicians, 1,446 participated in examining a total of 33,044 patients initially and 31,229 at the one-year follow-up.
2. Approximately 24.8 percent of patients in the physician outreach group participated in a FIT screening, compared to 21.7 percent in the regional participation group and 20.6 percent in the usual care group.
3. Between-group differences in relation to FIT screening were 3.1 percent for the list group over the regional group and 4.2 percent for the list group over the usual care group.
Researchers concluded, "Providing [providers] caring for adults at average risk of CRC with a list of their patients who were not up-to-date with their CRC screening resulted in a small but significant increase in patient participation in FIT screening at one year compared with patients who received usual care. Providing [physicians] with generic reminders about regional rates of CRC screening did not increase screening rates compared with usual care."
More article on gastroenterology:
Stock market week-in-review for 5 large GI companies — Aug. 28-Sept. 1
GI leader to know: Dr. Mark Cossentino of Endoscopy Center of El Paso
GI center to know: Endoscopy Center of El Paso